0001140361-23-004733.txt : 20230206
0001140361-23-004733.hdr.sgml : 20230206
20230206174127
ACCESSION NUMBER: 0001140361-23-004733
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230202
FILED AS OF DATE: 20230206
DATE AS OF CHANGE: 20230206
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Santos David A
CENTRAL INDEX KEY: 0001820066
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-29889
FILM NUMBER: 23591764
MAIL ADDRESS:
STREET 1: RIGEL PHARMACEUTICALS, INC.
STREET 2: 1180 VETERANS BLVD.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: RIGEL PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001034842
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943248524
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1180 VETERANS BOULEVARD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
MAIL ADDRESS:
STREET 1: 1180 VETERANS BOULEVARD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
form4.xml
X0306
4
2023-02-02
0001034842
RIGEL PHARMACEUTICALS INC
RIGL
0001820066
Santos David A
RIGEL PHARMACEUTICALS, INC.
611 GATEWAY BLVD, SUITE 900
SOUTH SAN FRANCISCO
CA
94080
true
EVP, Chief Commercial Officer
Common Stock
2023-02-02
4
S
0
5388
1.6602
D
144612
D
These shares were sold to cover tax withholding due upon vesting of Restricted Stock Units. Such "sales to cover" were automatically effected to satisfy tax withholding obligations and do not represent a discretionary trade by the Reporting Person.
/s/ Raymond Furey (Attorney-in-Fact)
2023-02-06